Better Access to Liver Cancer Medicines
Severe hepatitis in children
Recent Australian media articles have reported cases of severe hepatitis (inflammation of the liver) of…Read Article
For the love of chocolate: Tips to survive Easter
Hands up how many people over indulge in chocolate and other sweet treats this time…Read Article
Do you really need to detox your liver?
Liver detox diets and supplements are increasingly popular, especially in January when many people like…Read Article
Australians living with liver cancer will soon have new treatment options with changes to the Pharmaceutical Benefits Scheme (PBS) coming into effect.
The changes include better access to treatments for patients with advanced unresectable hepatocellular carcinoma. Unresectable hepatocellular carcinoma is the most common form of liver cancer, which often occurs in people with other chronic liver diseases. It also has one of the lowest survival rates of all cancer types.
From 1 November, more than 500 patients per year could benefit from PBS listing of this treatment, which would otherwise cost more than $170,000 per course. Australia will be the first country in the world to have this combination treatment publically funded for this type of liver cancer.